AzTrials
AzTrials

Brain ExcitabilityNCT05001425

Association Between the Brain Excitability and Postoperative Delirium in Patients Undergoing Heart Valve Replacement Surgery With Cardiopulmonary Bypass

An observational study of Brain Excitability and Postoperative Delirium, run by General Hospital of Ningxia Medical University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to explorethe brain excitability in patients undergoing heart valve replacement surgery with cardiopulmonary bypass and the correlation with postoperative delirium Read more about this study

Who is it for?
Any age
How many people
90 participants
Where
1 siteChina
Study dates
1 Jul 2020to 1 Dec 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: The patients undergoing heart valve replacement surgery with cardiopulmonary bypass

Who may be able to join

  • ASA Ⅱ - Ⅲ;
  • No cognitive impairment was assessed one day before surgery;
  • Patients undergoing elective heart valve replacement under CPB and signed informed consent.

Who cannot join

  • Non-CPB surgery, macrovascular surgery, heart transplantation, correction of congenital heart disease;
  • Stroke, schizophrenia, depression, Parkinson's disease, epilepsy or dementia;
  • Inability to communicate with language impairment or major hearing or visual impairment;
  • Liver function child-pugh Grade C, severe liver dysfunction;
  • Severe renal insufficiency requires preoperative renal replacement therapy;
  • A past history of intraoperative knowledge.

Trial locations and contacts

1 site in 1 country.

Xinli Ni, doctor contact

86-951-674-3252

xinlini6@nyfy.com.cn

Na Li, doctor contact

18509526253

anilln@163.com

China1 site, 1 recruiting
  • General Hospital of Ningxia Medical University

    Yinchuan, Ningxia, 750004

    Xinli Ni, PhD,MD, 86-951-674-3252, xinlini6@yahoo.com

    Recruiting

Other trials in China

About this study

Official title: Association Between the Brain Excitability and Postoperative Delirium in Patients Undergoing Heart Valve Replacement Surgery With Cardiopulmonary Bypass: a Prospective Cohort Study

The purpose of this study is to explorethe brain excitability in patients undergoing heart valve replacement surgery with cardiopulmonary bypass and the correlation with postoperative delirium

Read the detailed description

Delirium is the most common surgical patients postoperative complications of brain dysfunction. Delirium is a kind of consciousness attention and cognitive function changes of acute brain dysfunction, with volatility and reversibility of postoperative delirium (POD), increased hospital costs and length of hospital stay and mortality rate, and can lower the quality of life, lead to long-term postoperative cognitive dysfunction and dementia. The incidence of postoperative cognitive dysfunction in patients undergoing cardiac valve replacement under cardiopulmonary bypass (CPB) can be as high as 44-53%. However, since the specific mechanism of POD is still not clear, there is still a lack of effective prevention and treatment measures. Therefore, early detection and identification are helpful for the early treatment of POD.When brain injury occurs, the levels of excitatory neurotransmitters (glutamate and aspartate) will rise in a short period of time, and the high concentration of glutamate causes excessive intracellular calcium flow, causing cellular calcium overload, and generating excitatory cytotoxic effects. And abnormal electroencephalogram (EEG) is a kind of due to brain excitability/inhibitory amino acid imbalance caused by brain excitability increased result in abnormal discharge mode, can affect cognitive awareness and activities. Increased brain excitability is harmful to the potential, should avoid to happen. At present, the relationship between brain excitability and POD is still in exploring. Therefore, it is important to clarify the correlation between brain excitability and POD in patients undergoing cardiac valve replacement under CPB for improving the pathogenesis of POD.

Keywords
Brain excitability, Postoperative Delirium, Abnormal EEG, Excitatory amino acid, Heart valve replacement surgery
Medical subject headings
Emergence Delirium

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The incidence of delirium after cardiac surgery

    Postoperative evaluation delirium occurrence use the The Confusion Assessment Method(CAM) or The Confusion Assessment Method-intensive care unit(CAM-ICU).

    Measured: The first day after surgery

  2. The incidence of delirium after cardiac surgery

    Postoperative evaluation delirium occurrence use the The Confusion Assessment Method(CAM) or The Confusion Assessment Method-intensive care unit(CAM-ICU).

    Measured: The second day after surgery

  3. The incidence of delirium after cardiac surgery

    Postoperative evaluation delirium occurrence use the The Confusion Assessment Method(CAM) or The Confusion Assessment Method-intensive care unit(CAM-ICU).

    Measured: The third day after surgery

  4. Abnormal EEG during surgery

    The EEG was collected by Masimo instrument, and the EEG was recognized by the neuroelectrophysiologist, to identify whether the EEG of the patient was epileptic discharge and burst suppression during anesthesia

    Measured: Complete EEG information from entry to exit of the operating room

  5. Plasma excitatory amino acid levels

    Venous blood 5ml was collected and centrifuged (3500r/min,10min),sera were separated and put into -80 deep temperature refrigerator for testing plasma excitatory amino acid levels.

    Measured: Before the operation after entering the operating room (baseline)

  6. Plasma excitatory amino acid levels

    Venous blood 5ml was collected and centrifuged (3500r/min,10min),sera were separated and put into -80 deep temperature refrigerator for testing plasma excitatory amino acid levels.

    Measured: Immediately after surgery

  7. Plasma excitatory amino acid levels

    Venous blood 5ml was collected and centrifuged (3500r/min,10min),sera were separated and put into -80 deep temperature refrigerator for testing plasma excitatory amino acid levels.

    Measured: 24 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Aug 2021
  2. Study start1 Jul 2020
  3. Primary completion1 Dec 2021 (estimated)
  4. Study completion1 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05001425
Sponsor's protocol ID
LN 2021-1
Status last verified
Aug 2021
First submitted
27 Jul 2021
Last updated
12 Aug 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Brain Excitability and Postoperative Delirium, run by General Hospital of Ningxia Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Xinli Ni, doctor (86-951-674-3252, xinlini6@nyfy.com.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The incidence of delirium after cardiac surgery (time frame: The first day after surgery). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in